MMR Vaccine Not Linked to IBS, Autism
LONDON-Contradicting a previous report, a new study published in the September issue of Archives of Disease in Childhood shows receiving a childhood vaccine for measles, mumps, and rubella (MMR) does not increase the risk of developing inflammatory bowel disease (IBS) or autism.
Contrary to reports from a 1990s study from the Inflammatory Bowel Disease Study Group, the article argues there is no link between the vaccine and IBS.
David Elliman, MD, from St. George's Hospital, and Helen Bedford, MD, from the Institute of Child Health report no study has found evidence to support the association between the vaccine and autism, or IBS. The researchers took into account a new survey of children who received the vaccine and were followed for three years.
The American Academy of Pediatrics has also reported that there is no evidence to support the link between the vaccine and autism or IBS.
They concluded that physicians should not be hesitant in giving the vaccine because its efficacy has been proven.
Information from www.givenimaging.com, Reuters Health
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
